CEO Andreas Bhagwani is interviewed at Redeye after the release of the interim report Q2 2023
8 July, 2023
Intervju med vd Andreas Bhagwani gällande delårsrapporten för Q2 2023.
NLAB Saga®
A NEW GENERATION SILICA FOR PREPARATIVE CHROMATOGRAPHY
NLAB Saga® is a perfectly spherical, fully porous silica with superior mechanical stability and exceptional
chemical stability at high and low pH, making it an optimum choice for large scale purification of peptides.
ABOUT NANOLOGICA
Nanologica is a Swedish nanotechnology company, world-leading in the development of
nanoporous silica particles for purification by chromatography.
We aim to make a positive impact to the world by leveraging our expertise for the betterment of mankind.
Our mission is to increase the availability of cost-effective drugs, enabling more patients around the world access to vital treatments for diabetes and obesity.
Chromatography is a widely used technique for separating components in a mixture. We are active mainly in preparative chromatography, which is used by pharmaceutical manufacturers for purification of drugs, e.g. insulin, during production.
Through a proprietary production method, we create silica-based products that can purify more effectively and that last longer. This can
reduce production costs and increase productivity for pharmaceutical manufacturers.
News
Interim Report Q2 2023 Nanologica AB (publ)
7 July, 2023
FINANCIAL SUMMARY Net sales for the second quarter amounted to TSEK 672 (210) and for the half-year to TSEK 1,026 (479) The operating loss for the quarter amounted to TSEK -13,312 (-12,397) and for the half-year to TSEK -24,032 (-27,989) Loss after tax for the quarter amounted to TSEK -14,671 (-13,473) and for the half-year
Nanologica söker en Business Controller
29 June, 2023
Är du driven och motiveras av varierande arbetsuppgifter? Har du erfarenhet från producerande noterat bolag? Lockas du av en expansiv innovativ verksamhet? Då kan du vara den Business Controller som Nanologica söker! Vad får dig att trivas hos uppdragsgivaren Hos Nanologica får du jobba på ett bolag som vill förbättra för mänskligheten genom att bidra
Listen to our team talk about Nlab Saga®
Play Video about Katarina Alenäs – SVP Chromatography
Interview with Katarina Alenäs,
SVP Chromatography
Play Video
Interview with Olga Krivosheeva, Ph.D.
Application Project Manager
Play Video
Interview with Chunfang Zhou, Ph.D.
Sales Manager China
Nanologica is a public company listed for trade on Nasdaq Stockholm Main Market. For information regarding financial reports, press releases, presentations and share holder information, please visit our investor relations section.
Presentation of Nanologica
For more videos presentations of the company and of interim reports, please refer to Investor Relations.
Company presentation made by CEO Andreas Bhagwani in June, 2023.
Investor Pitch Deck September 2023.
Please contact us at ir@nanologica.com for more information.